Literature DB >> 20377975

Early endovascular management of oculomotor nerve palsy associated with posterior communicating artery aneurysms.

A Santillan1, W E Zink, J Knopman, H A Riina, Y P Gobin.   

Abstract

Palsy of the third cranial nerve (oculomotor nerve, CNIII) is a well-known clinical presentation of posterior communicating artery (P-com) aneurysm. We report a series of 11 patients with partial or complete third nerve palsy secondary to P-com aneurysm. All were treated with endovascular embolization within seven days of symptom onset. Third nerve palsy symptoms resolved in 7/11 (64%), improved in 2/11 (18%) and did not change in 2/11 (18%) patients.

Entities:  

Mesh：

Year:  2010        PMID： 20377975      PMCID： PMC3277961          DOI： 10.1177/159101991001600102

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN： 1591-0199            Impact factor:   1.610


  20 in total

1.  Clipping vs coiling of posterior communicating artery aneurysms with third nerve palsy.

Authors:  J Y Ahn; I B Han; P H Yoon; S H Kim; N K Kim; S Kim; J Y Joo
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

2.  Outcome of oculomotor nerve palsy from posterior communicating artery aneurysms: comparison of clipping and coiling.

Authors:  Peng R Chen; Sepideh Amin-Hanjani; Felipe C Albuquerque; Cameron McDougall; Joseph M Zabramski; Robert F Spetzler
Journal:  Neurosurgery       Date:  2006-06       Impact factor: 4.654

3.  Postoperative recovery of third nerve palsy due to posterior communicating aneurysms.

Authors:  T Kyriakides; T Z Aziz; M J Torrens
Journal:  Br J Neurosurg       Date:  1989       Impact factor: 1.596

4.  Magnetic resonance angiography and clinical evaluation of third nerve palsies and posterior communicating artery aneurysms.

Authors:  Mark J Kupersmith; Gordon Heller; Terry A Cox
Journal:  J Neurosurg       Date:  2006-08       Impact factor: 5.115

5.  Early surgery improves the cure of aneurysm-induced oculomotor palsy.

Authors:  S Leivo; J Hernesniemi; M Luukkonen; M Vapalahti
Journal:  Surg Neurol       Date:  1996-05

6.  Resolution of third nerve paresis after endovascular management of aneurysms of the posterior communicating artery.

Authors:  D Birchall; M S Khangure; W McAuliffe
Journal:  AJNR Am J Neuroradiol       Date:  1999-03       Impact factor: 3.825

7.  Literature review regarding the methodology of assessing third nerve paresis associated with non-ruptured posterior communicating artery aneurysms.

Authors:  Vassilios G Dimopoulos; Kostas N Fountas; Carlos H Feltes; Joe Sam Robinson; Arthur A Grigorian
Journal:  Neurosurg Rev       Date:  2005-06-10       Impact factor: 3.042

8.  Prognosis of oculomotor palsy in patients with aneurysms of the posterior communicating artery.

Authors:  J Hamer
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

9.  Unruptured aneurysms presenting with mass effect symptoms: response to endosaccular treatment with Guglielmi detachable coils. Part I. Symptoms of cranial nerve dysfunction.

Authors:  T W Malisch; G Guglielmi; F Viñuela; G Duckwiler; Y P Gobin; N A Martin; J G Frazee; J S Chmiel
Journal:  J Neurosurg       Date:  1998-12       Impact factor: 5.115

10.  Orbital pain and unruptured carotid-posterior communicating artery aneurysms: the role of sensory fibers of the third cranial nerve.

Authors:  G Lanzino; A Andreoli; F Tognetti; P Limoni; F Calbucci; R Bortolami; M L Lucchi; E Callegari; C Testa
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216
View more
  9 in total

1.  Recovery of ophthalmoplegia after endovascular treatment of intracranial aneurysms.

Authors:  V Panagiotopoulos; S C Ladd; E Gizewski; S Asgari; E I Sandalcioglu; M Forsting; I Wanke
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-11       Impact factor: 3.825

2.  Successful endovascular management of brain aneurysms presenting with mass effect and cranial nerve palsy.

Authors:  Tamer Hassan; Ahmed Hamimi
Journal:  Neurosurg Rev       Date:  2012-07-11       Impact factor: 3.042

3.  Endovascular repair of posterior communicating artery aneurysms, associated with oculomotor nerve palsy: A review of nerve recovery.

Authors:  Mark John Sheehan; Ruth Dunne; John Thornton; Paul Brennan; Seamus Looby; Alan O'Hare
Journal:  Interv Neuroradiol       Date:  2015-05-26       Impact factor: 1.610

Review 4.  Endovascular treatment of posterior communicating artery aneurysms with oculomotor nerve palsy: clinical outcomes and predictors of nerve recovery.

Authors:  N Chalouhi; T Theofanis; P Jabbour; A S Dumont; L F Gonzalez; R M Starke; D Gordon; R Rosenwasser; S Tjoumakaris
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-04       Impact factor: 3.825

5.  Flow-diverter stents for endovascular management of non-fetal posterior communicating artery aneurysms-analysis on aneurysm occlusion, vessel patency, and patient outcome.

Authors:  Anna Luisa Kühn; Guilherme Dabus; Peter Kan; Ajay K Wakhloo; Ajit S Puri
Journal:  Interv Neuroradiol       Date:  2018-02-22       Impact factor: 1.610

6.  Stent-Assisted Coil Embolization of Posttraumatic Dissecting Carotid Aneurysm Causing Ophthalmoplegia.

Authors:  Kaan Esen; Huseyin Naim Eriş; Altan Yildiz; Engin Kara; Anil Ozgur
Journal:  Pol J Radiol       Date:  2017-06-10

7.  Neuro-ophthalmological manifestations of tuberous sclerosis: current perspectives.

Authors:  Michael J Wan; Ka Lo Chan; Benjamin G Jastrzembski; Asim Ali
Journal:  Eye Brain       Date:  2019-06-19

8.  Recovery of oculomotor nerve palsy after endovascular management of posterior communicating artery aneurysms.

Authors:  Elkharbash Abdurahman; Khatija Amod; Duncan Royston; Rohen Harrichandparsad
Journal:  SA J Radiol       Date:  2020-08-31

9.  Variation of Mass Effect After Using a Flow Diverter With Adjunctive Coil Embolization for Symptomatic Unruptured Large and Giant Intracranial Aneurysms.

Authors:  Zhongxiao Wang; Zhongbin Tian; Wenqiang Li; Jiejun Wang; Wei Zhu; Mingqi Zhang; Ying Zhang; Jian Liu; Kun Wang; Yisen Zhang; Xinjian Yang
Journal:  Front Neurol       Date:  2019-11-12       Impact factor: 4.003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.